查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2088865

生物外科市場：2026-2032年全球市場預測（按產品類型、材料類型、吸收性、應用和最終用戶分類）

Biosurgery Market by Product Type, Material Type, Resorbability, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，生物外科市場將成長至 334.3 億美元，複合年成長率為 8.75%。

主要市場統計數據
基準年 2025 185.8億美元
預計年份：2026年 201.4億美元
預測年份：2032年 334.3億美元
複合年成長率 (%) 8.75%

生物外科市場位於手術安全、生物材料和手術室效率的交會點。全球手術量巨大、人口老化、創傷治療需求以及微創但複雜的手術模式的不斷轉變（在這些手術中，止血、組織封閉、預防粘連和軟組織加固具有重要的臨床意義）共同推動了市場需求。

止血劑、外科密封劑、防粘連劑、骨移植替代物和先進傷口縫合技術的應用推動了市場成長。醫院和門診手術中心越來越重視基於可衡量的結果來評估這些產品，例如減少出血量、縮短手術時間、減少併發症、降低輸血需求以及提升醫療保健價值。

生物外科領域的變革性變化

バイオ外科のセグメントは、手術の複雑化、コスト管理、製品革新という3つの要因によって変革が進んでいます。生物來源または合成の補助材が、より迅速な止血、より確実な組織の密閉、あるいは術後の癒着の低減を可能にする場合、外科医たちは従来型縫合糸、クリップ、焼灼法といった手法から脱却しつつあります。

人工智慧（AI）的累積影響

人工智慧 (AI) 正透過手術規劃、產品選擇、庫存最佳化和實證醫學證據產生等方式，開始影響生物外科領域。 AI 驅動的分析可以幫助醫院識別高風險手術類型，預測止血裝置、密封劑和黏連抑制劑的使用情況，並減少因過期或分配不當造成的產品浪費。

全球生物外科領域的關鍵區域洞察

亞太地區的生物外科領域正經歷強勁成長，這主要得益於手術能力的提升、醫療保健支出的增加以及中國、印度、日本、韓國和澳洲等國手術量的顯著成長。該地區受益於公立醫院的擴建、私立專科醫療機構的發展、本地製造業的舉措、醫療旅遊的興起以及政府對手術室基礎設施的投資，所有這些因素都在不斷擴大止血劑、手術密封劑、防粘連劑和再生醫學產品的供應。

生物外科市場中的關鍵群體特定洞察

隨著印尼、泰國、越南、馬來西亞和菲律賓不斷提升手術室容量、完善全民健保系統並加大對私人醫療網路的投資，東協市場的重要性日益凸顯。這些趨勢正推動生物外科產品在一般外科、婦產科、整形外科和創傷護理等領域的逐步應用。在海灣合作理事會（GCC）成員國，先進的生物外科產品正透過專科醫院、國家醫療改革計畫和醫療城計畫引入，尤其是在心血管、整形外科、腫瘤和急診外科領域。

各國生物外科手術應用的關鍵具體見解。

美國憑藉其龐大的先進外科手術量、一體化的醫院網路、大學附屬醫院以及在心血管外科、整形外科、脊柱外科、創傷外科、移植外科和普通外科中廣泛使用止血劑和閉塞劑，引領著生物外科技術的應用。加拿大則優先考慮循證採購和醫療技術評估，而墨西哥和巴西則受益於私立醫院的擴張、對專科手術需求的成長以及先進外科耗材獲取管道的改善。

生物外科行業領導者使用的實用建議

產業領導者應優先考慮具有臨床差異化的生物外科產品，這些產品應展現出更快的止血速度、可靠的密封性、可控的吸收、良好的生物相容性、更低的粘連風險以及在實際手術流程中易於操作等特點。證據應不僅限於關鍵的臨床試驗，還應包括註冊研究數據、臨床結果比較、健康經濟學模型以及醫院層面的績效指標，以支持基於經濟分析的決策。

生物外科領域的創新調查方法

本執行摘要は、確立された市場情報基準に沿った二次調査と分析的研究途徑を用いて作成されています。入力データには、公開されている規制ガイダンス、病院の調達動向、外科的止血、組織シーリング、傷口縫合、骨再生、癒着予防に関する臨床文献、手術件数指標、医療インフラの最新情報、公的機関が提供するマクロ経済的な医療データセットが含まれます。

結論

隨著醫院致力於提高手術安全性、降低併發症風險、改善血液管理以及更有效地利用資源，生物外科正成為現代外科醫學的核心要素。在手術複雜程度高、人口老化、創傷救治需求旺盛且醫療投資集中的地區，生物外科的需求最為旺盛。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：生物外科市場：依產品類型分類

  • 止血劑
  • 密封劑和黏合劑
  • 組織移植

第8章：生物外科市場：依材料類型分類

  • 膠原蛋白蛋白
  • 纖維蛋白系統
  • 明膠基
  • 合成

第9章：生物外科市場：可吸收材料

  • 不吸收
  • 吸收性
    • 完全吸收
    • 部分吸收

第10章：生物外科市場：依應用領域分類

  • 心血管外科
    • 心臟繞道手術
    • 瓣膜修復手術
  • 一般外科
    • 疝氣修補術
    • 傷口修復
  • 微創手術
    • 內視鏡
    • 腹腔鏡
  • 開放性手術
  • 整形外科手術
    • 關節重建手術
    • 脊椎固定

第11章：生物外科市場：依最終用戶分類

  • 門診手術中心
  • 醫院
  • 專科診所
    • 牙醫診所
    • 眼科診所

第12章：生物外科市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章：生物外科市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：生物外科市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Advanced Medical Solutions Group plc
  • Artivion, Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • BioCer Entwicklungs-GmbH
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Corza Medical GmbH
  • CryoLife, Inc.
  • CSL Limited
  • Hemostasis, LLC
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson
  • Kuros Bioscience AG
  • Medtronic plc
  • Pfizer Inc.
  • RTI Surgical, Inc.
  • Samyang Holdings Corporation
  • Sanofi SA
  • Smith & Nephew plc
  • Stryker Corporation
  • Teleflex Incorporated
  • Tissue Regenix Ltd
  • Vivostat A/S
Product Code: MRR-AD36CD8982F7

The Biosurgery Market is projected to grow by USD 33.43 billion at a CAGR of 8.75% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 18.58 billion
Estimated Year [2026] USD 20.14 billion
Forecast Year [2032] USD 33.43 billion
CAGR (%) 8.75%

The biosurgery market sits at the intersection of surgical safety, biologic materials, and operating-room efficiency. Demand is supported by high global surgical volumes, aging populations, trauma care needs, and the steady shift toward minimally invasive and complex procedures where bleeding control, tissue sealing, adhesion prevention, and soft-tissue reinforcement are clinically important.

Market growth is shaped by the adoption of hemostatic agents, surgical sealants, adhesion barriers, bone graft substitutes, and advanced wound closure technologies. Hospitals and ambulatory surgery centers increasingly evaluate these products on measurable outcomes, including reduced blood loss, shorter procedure time, fewer complications, lower transfusion requirements, and alignment with value-based care.

Transformative Shifts in the Biosurgery Landscape

The biosurgery landscape is being transformed by three forces: procedure complexity, cost accountability, and product innovation. Surgeons are moving beyond conventional sutures, clips, and cautery when biologic or synthetic adjuncts can support faster hemostasis, more reliable tissue sealing, or reduced post-operative adhesions.

Manufacturers are responding with ready-to-use formulations, combination products, absorbable matrices, fibrin sealants, synthetic sealants, and regenerative biomaterials designed for laparoscopy, cardiovascular surgery, orthopedic surgery, neurosurgery, trauma care, and general surgery. At the same time, hospital value analysis committees are demanding stronger clinical evidence, transparent pricing, training support, and real-world performance data before adding biosurgery products to formularies.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is beginning to influence biosurgery through surgical planning, product selection, inventory optimization, and evidence generation. AI-enabled analytics can help hospitals identify procedure types with higher bleeding risk, forecast usage of hemostats, sealants, and adhesion barriers, and reduce waste from expired or misallocated products.

In research and development, machine learning supports biomaterial screening, protein engineering, polymer design, preclinical biocompatibility assessment, and literature-based safety signal detection. While AI does not replace surgeon judgment, it can accelerate data interpretation, strengthen post-market surveillance, and support more personalized use of biosurgical products when integrated with validated clinical workflows, cybersecurity controls, and compliant data governance.

Key Regional Insights Across Global Biosurgery

Asia-Pacific is a high-growth biosurgery region, supported by expanding surgical capacity, rising healthcare expenditure, and strong procedure volumes in China, India, Japan, South Korea, and Australia. The region benefits from public hospital expansion, private specialty care growth, local manufacturing initiatives, medical tourism, and government investments in operating-room infrastructure, which continue to widen access to hemostatic agents, surgical sealants, adhesion barriers, and regenerative surgical products.

North America remains a leading biosurgery region due to advanced hospital systems, high adoption of premium surgical technologies, mature trauma and cardiovascular care pathways, and established reimbursement mechanisms. Europe benefits from standardized clinical practice, strong surgeon training, and centralized regulatory oversight under medical device frameworks, supporting evidence-driven adoption. Latin America shows selective expansion in Brazil and Mexico, where private healthcare, specialty surgery, and tertiary hospital investment are improving access. The Middle East is investing in tertiary care centers, medical cities, and advanced surgical specialties, while Africa presents long-term opportunity as surgical access, workforce development, and hospital infrastructure improve, although affordability, procurement fragmentation, and supply-chain reliability remain key constraints.

Key Group Insights Across Biosurgery Markets

ASEAN markets are increasingly important as Indonesia, Thailand, Vietnam, Malaysia, and the Philippines invest in operating-room capacity, universal health coverage initiatives, and private healthcare networks. These developments support gradual adoption of biosurgery products in general surgery, obstetrics and gynecology, orthopedics, and trauma care. GCC countries are adopting advanced biosurgery products through specialty hospitals, national health transformation programs, and medical-city projects, particularly for cardiovascular, orthopedic, oncology-related, and emergency surgical procedures.

The European Union emphasizes safety, clinical documentation, traceability, and post-market evidence under the Medical Device Regulation, influencing product timelines, labeling, and competitive positioning. BRICS countries provide scale through large patient populations, expanding surgical infrastructure, and domestic manufacturing policies that encourage cost-sensitive product portfolios. G7 markets remain innovation-led, with strong uptake of premium surgical sealants, hemostatic agents, and absorbable matrices supported by advanced clinical pathways and value-based procurement. NATO-aligned procurement environments can strengthen demand for trauma, emergency surgery, field care, and military medical readiness applications, where fast hemostasis, portability, and dependable supply are critical.

Key Country Insights Across Biosurgery Adoption

The United States leads biosurgery adoption through advanced surgical volumes, integrated hospital networks, academic medical centers, and broad use of hemostatic and sealing products in cardiovascular, orthopedic, spine, trauma, transplant, and general surgery. Canada prioritizes evidence-based procurement and health technology assessment, while Mexico and Brazil are driven by private hospital expansion, growing specialty procedure demand, and improving access to advanced surgical consumables.

In Europe, the United Kingdom, Germany, France, Italy, and Spain show steady biosurgery demand linked to aging populations, surgical modernization, cancer care, orthopedic procedures, and cardiovascular interventions, while Russia faces a more localized and import-sensitive supply environment. China and India are major growth engines due to large procedure volumes, healthcare infrastructure expansion, domestic manufacturing, and widening access to advanced surgical care. Japan emphasizes high-quality surgical technology, infection control, and aging-related procedure demand; South Korea supports adoption through advanced hospital infrastructure and strong surgical innovation; and Australia benefits from rigorous clinical standards, specialty care networks, and established reimbursement pathways for complex procedures.

Actionable Recommendations for Biosurgery Industry Leaders

Industry leaders should prioritize clinically differentiated biosurgery products that demonstrate faster hemostasis, reliable sealing, controlled absorption, biocompatibility, reduced adhesion risk, and ease of use in real surgical workflows. Evidence should extend beyond pivotal studies to include registry data, comparative clinical outcomes, health-economic models, and hospital-level performance metrics that support value analysis decisions.

Organizations should also localize regulatory, reimbursement, and distribution strategies by region. Partnerships with surgeons, teaching hospitals, procurement networks, emergency care programs, and digital surgery platforms can improve adoption and appropriate product use. A resilient supply chain, surgeon training programs, procedure-specific education, and AI-enabled demand forecasting will be essential to protect margins, reduce wastage, and ensure product availability across routine and emergency surgical settings.

Research Methodology for Biosurgery Insights

This executive summary is developed using a secondary and analytical research approach aligned with established market intelligence standards. Inputs include public regulatory guidance, hospital procurement trends, clinical literature on surgical hemostasis, tissue sealing, wound closure, bone regeneration, and adhesion prevention, procedure-volume indicators, healthcare infrastructure updates, and macroeconomic healthcare datasets from recognized public institutions.

Market interpretation is strengthened through triangulation across product categories, surgical specialties, end-user settings, care delivery models, and regional demand drivers. Insights are validated for consistency with known clinical practice patterns, regulatory requirements, reimbursement dynamics, and healthcare investment trends, while avoiding unsupported claims, speculative assumptions, market estimation, market sizing, market share analysis, or market forecasting.

Conclusion

Biosurgery is becoming a core component of modern operative care as hospitals pursue safer procedures, lower complication risk, better blood management, and improved resource utilization. Demand is strongest where surgical complexity, aging demographics, trauma care needs, and healthcare investment converge.

The next phase of competition will favor organizations that combine strong clinical evidence, surgeon-friendly product design, regulatory discipline, supply-chain resilience, and data-enabled commercialization. Artificial intelligence, localized market access, and measurable health-economic value will increasingly define leadership in the global biosurgery market.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Biosurgery Market, by Product Type

  • 7.1. Hemostats
  • 7.2. Sealants & Adhesives
  • 7.3. Tissue Grafts

8. Biosurgery Market, by Material Type

  • 8.1. Collagen-Based
  • 8.2. Fibrin-Based
  • 8.3. Gelatin-Based
  • 8.4. Synthetic

9. Biosurgery Market, by Resorbability

  • 9.1. Nonresorbable
  • 9.2. Resorbable
    • 9.2.1. Fully Resorbable
    • 9.2.2. Partially Resorbable

10. Biosurgery Market, by Application

  • 10.1. Cardiovascular Surgery
    • 10.1.1. Bypass Surgery
    • 10.1.2. Valve Repair
  • 10.2. General Surgery
    • 10.2.1. Hernia Repair
    • 10.2.2. Wound Repair
  • 10.3. Minimally Invasive Surgery
    • 10.3.1. Endoscopic
    • 10.3.2. Laparoscopic
  • 10.4. Open Surgery
  • 10.5. Orthopedic Surgery
    • 10.5.1. Joint Replacement
    • 10.5.2. Spinal Fusion

11. Biosurgery Market, by End User

  • 11.1. Ambulatory Surgery Centers
  • 11.2. Hospitals
  • 11.3. Specialty Clinics
    • 11.3.1. Dental Clinics
    • 11.3.2. Ophthalmology Clinics

12. Biosurgery Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Biosurgery Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Biosurgery Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Advanced Medical Solutions Group plc
  • 16.2. Artivion, Inc.
  • 16.3. B. Braun Melsungen AG
  • 16.4. Baxter International Inc.
  • 16.5. Becton, Dickinson and Company
  • 16.6. BioCer Entwicklungs-GmbH
  • 16.7. Boston Scientific Corporation
  • 16.8. Cardinal Health, Inc.
  • 16.9. Corza Medical GmbH
  • 16.10. CryoLife, Inc.
  • 16.11. CSL Limited
  • 16.12. Hemostasis, LLC
  • 16.13. Integra LifeSciences Holdings Corporation
  • 16.14. Johnson & Johnson
  • 16.15. Kuros Bioscience AG
  • 16.16. Medtronic plc
  • 16.17. Pfizer Inc.
  • 16.18. RTI Surgical, Inc.
  • 16.19. Samyang Holdings Corporation
  • 16.20. Sanofi SA
  • 16.21. Smith & Nephew plc
  • 16.22. Stryker Corporation
  • 16.23. Teleflex Incorporated
  • 16.24. Tissue Regenix Ltd
  • 16.25. Vivostat A/S

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOSURGERY MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL BIOSURGERY MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL BIOSURGERY MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL BIOSURGERY MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL BIOSURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIOSURGERY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL BIOSURGERY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL BIOSURGERY MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL BIOSURGERY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL BIOSURGERY MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL BIOSURGERY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL BIOSURGERY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL BIOSURGERY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL BIOSURGERY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL BIOSURGERY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL BIOSURGERY MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL BIOSURGERY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BIOSURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HEMOSTATS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HEMOSTATS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SEALANTS & ADHESIVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SEALANTS & ADHESIVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SEALANTS & ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL TISSUE GRAFTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL TISSUE GRAFTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL TISSUE GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL COLLAGEN-BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL COLLAGEN-BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL COLLAGEN-BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL FIBRIN-BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL FIBRIN-BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL FIBRIN-BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL GELATIN-BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL GELATIN-BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL GELATIN-BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SYNTHETIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SYNTHETIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SYNTHETIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL NONRESORBABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL NONRESORBABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NONRESORBABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL RESORBABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL RESORBABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL RESORBABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL FULLY RESORBABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL FULLY RESORBABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL FULLY RESORBABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PARTIALLY RESORBABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PARTIALLY RESORBABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PARTIALLY RESORBABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CARDIOVASCULAR SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CARDIOVASCULAR SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CARDIOVASCULAR SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BYPASS SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BYPASS SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BYPASS SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL VALVE REPAIR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL VALVE REPAIR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL VALVE REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL GENERAL SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL GENERAL SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL GENERAL SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL HERNIA REPAIR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL HERNIA REPAIR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL HERNIA REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL WOUND REPAIR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL WOUND REPAIR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL WOUND REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ENDOSCOPIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ENDOSCOPIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ENDOSCOPIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL LAPAROSCOPIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL LAPAROSCOPIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL LAPAROSCOPIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL OPEN SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL OPEN SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL OPEN SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ORTHOPEDIC SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ORTHOPEDIC SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ORTHOPEDIC SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL JOINT REPLACEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL JOINT REPLACEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL JOINT REPLACEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SPINAL FUSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SPINAL FUSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SPINAL FUSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BIOSURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL DENTAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL DENTAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL DENTAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL OPHTHALMOLOGY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL OPHTHALMOLOGY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL OPHTHALMOLOGY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL BIOSURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC BIOSURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA BIOSURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA BIOSURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA BIOSURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA BIOSURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE BIOSURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE BIOSURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST BIOSURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST BIOSURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA BIOSURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA BIOSURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL BIOSURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN BIOSURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN BIOSURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 180. GCC BIOSURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 181. GCC BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. GCC BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. GCC BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2032 (USD MILLION)
  • TABLE 184. GCC BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2032 (USD MILLION)
  • TABLE 185. GCC BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. GCC BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 187. GCC BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 188. GCC BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 189. GCC BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 190. GCC BIOSURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. GCC BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION BIOSURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION BIOSURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS BIOSURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS BIOSURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 216. G7 BIOSURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 217. G7 BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. G7 BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. G7 BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2032 (USD MILLION)
  • TABLE 220. G7 BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2032 (USD MILLION)
  • TABLE 221. G7 BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. G7 BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 223. G7 BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 224. G7 BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 225. G7 BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 226. G7 BIOSURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 227. G7 BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 228. NATO BIOSURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 229. NATO BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. NATO BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. NATO BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2032 (USD MILLION)
  • TABLE 232. NATO BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2032 (USD MILLION)
  • TABLE 233. NATO BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 234. NATO BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 235. NATO BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 236. NATO BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 237. NATO BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 238. NATO BIOSURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 239. NATO BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 240. GLOBAL BIOSURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES BIOSURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED STATES BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES BIOSURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED STATES BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 253. CANADA BIOSURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 254. CANADA BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. CANADA BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. CANADA BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2032 (USD MILLION)
  • TABLE 257. CANADA BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2032 (USD MILLION)
  • TABLE 258. CANADA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 259. CANADA BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 260. CANADA BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 261. CANADA BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 262. CANADA BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 263. CANADA BIOSURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 264. CANADA BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 265. MEXICO BIOSURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 266. MEXICO BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. MEXICO BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. MEXICO BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2032 (USD MILLION)
  • TABLE 269. MEXICO BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2032 (USD MILLION)
  • TABLE 270. MEXICO BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 271. MEXICO BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 272. MEXICO BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 273. MEXICO BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 274. MEXICO BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 275. MEXICO BIOSURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 276. MEXICO BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 277. BRAZIL BIOSURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 278. BRAZIL BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. BRAZIL BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 280. BRAZIL BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2032 (USD MILLION)
  • TABLE 281. BRAZIL BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2032 (USD MILLION)
  • TABLE 282. BRAZIL BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 283. BRAZIL BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 284. BRAZIL BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 285. BRAZIL BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 286. BRAZIL BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 287. BRAZIL BIOSURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 288. BRAZIL BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 289. UNITED KINGDOM BIOSURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 290. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 291. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 292. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2032 (USD MILLION)
  • TABLE 293. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2032 (USD MILLION)
  • TABLE 294. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 295. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 296. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 297. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 298. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 299. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 300. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 301. GERMANY BIOSURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 302. GERMANY BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 303. GERMANY BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 304. GERMANY BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2032 (USD MILLION)
  • TABLE 305. GERMANY BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2032 (USD MILLION)
  • TABLE 306. GERMANY BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 307. GERMANY BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 308. GERMANY BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 309. GERMANY BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 310. GERMANY BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 311. GERMANY BIOSURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 312. GERMANY BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 313. FRANCE BIOSURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 314. FRANCE BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 315. FRANCE BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 316. FRANCE BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2032 (USD MILLION)
  • TABLE 317. FRANCE BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2032 (USD MILLION)
  • TABLE 318. FRANCE BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 319. FRANCE BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 320. FRANCE BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 321. FRANCE BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 322. FRANCE BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 323. FRANCE BIOSURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 324. FRANCE BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 325. RUSSIA BIOSURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 326. RUSSIA BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 327. RUSSIA BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 328. RUSSIA BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2032 (USD MILLION)
  • TABLE 329. RUSSIA BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2032 (USD MILLION)
  • TABLE 330. RUSSIA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 331. RUSSIA BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 332. RUSSIA BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 333. RUSSIA BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 334. RUSSIA BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 335. RUSSIA BIOSURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 336. RUSSIA BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 337. ITALY BIOSURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 338. ITALY BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 339. ITALY BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 340. ITALY BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2032 (USD MILLION)
  • TABLE 341. ITALY BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2032 (USD MILLION)
  • TABLE 342. ITALY BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 343. ITALY BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 344. ITALY BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 345. ITALY BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 346. ITALY BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 347. ITALY BIOSURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 348. ITALY BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 349. SPAIN BIOSURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 350. SPAIN BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 351. SPAIN BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 352. SPAIN BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2032 (USD MILLION)
  • TABLE 353. SPAIN BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2032 (USD MILLION)
  • TABLE 354. SPAIN BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 355. SPAIN BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 356. SPAIN BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 357. SPAIN BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 358. SPAIN BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 359. SPAIN BIOSURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 360. SPAIN BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 361. CHINA BIOSURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 362. CHINA BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 363. CHINA BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 364. CHINA BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2032 (USD MILLION)
  • TABLE 365. CHINA BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2032 (USD MILLION)
  • TABLE 366. CHINA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 367. CHINA BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 368. CHINA BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 369. CHINA BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 370. CHINA BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 371. CHINA BIOSURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 372. CHINA BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 373. INDIA BIOSURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 374. INDIA BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 375. INDIA BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 376. INDIA BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2032 (USD MILLION)
  • TABLE 377. INDIA BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2032 (USD MILLION)
  • TABLE 378. INDIA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 379. INDIA BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 380. INDIA BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 381. INDIA BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 382. INDIA BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 383. INDIA BIOSURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 384. INDIA BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 385. JAPAN BIOSURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 386. JAPAN BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 387. JAPAN BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 388. JAPAN BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2032 (USD MILLION)
  • TABLE 389. JAPAN BIOSURGERY MA